Nutrition and Coronary Heart Disease
TABLE 4: LOWER BOUND, MIDPOINT AND UPPER BOUNDS OF EFFECTIVENESS FOR EACH
INTERVENTION.
|
INTERVENTION |
YEARS OF EFFECTIVENESS | ||
|
Lower Bound (years) |
Mid-Point (years) |
Upper bound (years) | |
|
-ɑp |
4 |
53 |
T |
|
Community |
2 |
3.5 |
5 |
|
Mass Media |
1 |
2 |
3 |
|
HospitaVRehab |
______________2 |
____________3.5 |
_____________5_ |
These assumptions will provide an upper and lower bound for the sensitivity analysis.
The sensitivity analysis will scrutinise the assumptions made above and test whether
varying the time span of a strategy will affect its cost-effectiveness ranking.
Effectiveness of the interventions
Through an examination of prevalence rates within the target groups, the number of
CHD events for each of the sub-groups can be estimated. Table 5 provides SWSAHS
population figures and the expected number of CHD deaths over one year. The figures
in Table 5 are for people in the 25 to 75 age group. Note that approximately 18 % of
CHD occur outside this age group. The table is compiled from a range of
epidemiological profiles, relative risk measures and CHD death statistics for the
SWSAHS. See Appendix C for a more detailed discussion on these figures.
CHERE Project Report IJ- November 1999
22
More intriguing information
1. Human Resource Management Practices and Wage Dispersion in U.S. Establishments2. Integrating the Structural Auction Approach and Traditional Measures of Market Power
3. Quality practices, priorities and performance: an international study
4. Labour Market Institutions and the Personal Distribution of Income in the OECD
5. Asymmetric transfer of the dynamic motion aftereffect between first- and second-order cues and among different second-order cues
6. The name is absent
7. The Provisions on Geographical Indications in the TRIPS Agreement
8. The name is absent
9. BEN CHOI & YANBING CHEN
10. Economic Evaluation of Positron Emission Tomography (PET) in Non Small Cell Lung Cancer (NSCLC), CHERE Working Paper 2007/6